UC Riverside professor receives NIH grant for neurodevelopmental disorder study

NewsGuard 100/100 Score

Iryna Ethell, a professor of biomedical sciences in the School of Medicine at the University of California, Riverside, has been awarded a five-year grant of $2.4 million from the National Institutes of Health to study mechanisms of hyperexcitability and seizures in neurodevelopmental disorders such as such as attention-deficit/hyperactivity disorder and autism.

In this project we will address critical gaps in our knowledge, such as what role do astrocytes play in inhibitory synapse development in the hippocampus. We expect our work will lead to the development of novel therapeutic targets to treat neurodevelopmental disorders, including autism spectrum disorder, schizophrenia, and epilepsy."

Iryna Ethell, professor of biomedical sciences, School of Medicine, University of California, Riverside

Astrocytes are star-shaped cells in the brain that are actively involved in brain function. They regulate synaptic connections between neurons. Each neuron in the brain receives numerous excitatory and inhibitory synaptic inputs. The balance between excitation and inhibition in neuronal circuits can play a role in causing many neurological disorders.

Ethell's lab has studied a protein called ephrin-B1, which spans the membrane surrounding the cell and plays a role in maintaining the nervous system. Preliminary findings from her lab show that loss of astrocytic ephrin-B1 increases susceptibility to seizures and reduces sociability in mice. 

EphB receptor signaling is a cellular pathway that regulates many developmental processes and is necessary for distributing and organizing synapses. Ethell explained that ephrin-B/EphB receptor signaling in the brain controls the development of inhibitory networks, that control brain excitability in a timely and special manner to ensure orderly brain functions and preventing seizures. 

"If you compare the brain to driving a car, your excitatory network is a gas pedal that initiates the brain responses, but inhibitory networks are the brakes to ensure it does not crash," Ethell said.

The research will use mouse models as well as state-of-art analysis and imaging approaches.

"We think this project will further our understanding of the mechanisms which lead to neurodevelopmental disorders and will allow us to discover novel interventions for treating these disorders by fixing abnormal inhibitory networks," Ethell said.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Expanding research and clinical options for children with cancer